Projects per year
Personal profile
Education
- 2005 Ph.D. Pharmaceutics, School of Pharmacy, The Ohio State University, USA
- 1998 M.S., Pharmacy National Taiwan University
- 1996 B.S., School of Pharmacy, National Taiwan University
Experience
- 2016- Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2013- Ph.D. Program in Clinical Drug Development of Herbal Medicine, Taipei Medical University
- 2012-2016 Assistant Professor, Department of Pharmaceutical Sciences,Taipei Medical University
- 2006-2012 Assistant Professor, School of Pharmacy, Taipei Medical University
Research Interests
- Delivery of gene/siRNA/antisense agents by nanoparticles or liposomes
- Targeted drug/gene/antisense delivery systems
- Nanoparticle design and synthesis
- Development of novel biomaterials for drug/gene/antisense delivery
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 7 Finished
-
口服矽奈米粒子安定性評估
Chiu, S.-J. (PI)
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
Applications of Multifunctionalized Nanoparticles for Chemotherapy Combined with Hdac Inhibitors against Triple-Negative Breast Cancer
Chiu, S.-J. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
(教學實踐) 結合數位學習與問題導向學習之教學策略以提升藥學系學生在藥用物理化學課程的學習興趣與成效
Chiu, S.-J. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › d - Ministry of Education
-
Development of Multifunctionalized Nanoparticles for Delivery of Chemotherapeutic Agents to Triple-Negative Breast Cancer
Chiu, S.-J. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
Multifunctional Nanoparticles for Cancer Therapy
Chiu, S.-J. (PI)
8/1/15 → 7/31/16
Project: A - Government Institution › b - National Science and Technology Council
-
Quantitative Analysis of Macrophage Uptake and Retention of Fluorescent Organosilica Nanoparticles: Implications for Nanoparticle Delivery and Therapeutics
Chou, H. C., Chiu, S. J. & Hu, T. M., Feb 23 2024, In: ACS Applied Nano Materials. 7, 4, p. 3656-3667 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
A macrolide from Streptomyces sp. modulates apoptosis and autophagy through Mcl-1 downregulation in human breast cancer cells
Chiu, C. F., Chiu, S. J., Bai, L. Y., Feng, C. H., Hu, J. L., Lin, W. Y., Huang, H. Y. & Weng, J. R., Jul 2021, In: Environmental Toxicology. 36, 7, p. 1316-1325 10 p.Research output: Contribution to journal › Article › peer-review
10 Citations (Scopus) -
Organosilica colloids as nitric oxide carriers: Pharmacokinetics and biocompatibility
Chou, H. C., Lo, C. H., Chang, L. H., Chiu, S. J. & Hu, T. M., Dec 2021, In: Colloids and Surfaces B: Biointerfaces. 208, 112136.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Author Correction: FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism (Scientific Reports, (2017), 7, 1, (5600), 10.1038/s41598-017-06047-9)
Bai, L. Y., Chiu, C. F., Chiu, S. J., Chu, P. C. & Weng, J. R., Dec 1 2020, In: Scientific Reports. 10, 1, 3322.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Citation (Scopus) -
NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer
Huang, T. Y., Chang, T. C., Chin, Y. T., Pan, Y. S., Chang, W. J., Liu, F. C., Hastuti, E. D., Chiu, S. J., Wang, S. H., Changou, C. A., Li, Z. L., Chen, Y. R., Chu, H. R., Shih, Y. J., Cheng, R. H., Wu, A., Lin, H. Y., Wang, K., Whang-Peng, J. & Mousa, S. A. & 1 others, , Aug 3 2020, In: Cells. 9, 8, 1826.Research output: Contribution to journal › Article › peer-review
Open Access22 Citations (Scopus)